glp-1 receptor agonists for weight loss Comparing Ozempic, Wegovy and Other Drugs GLP-1 Drug Savings: A Complete

Positive clinical evidence demonstrating improvements in liver inflammation and fibrosis is encouraging investment in late-stage clinical development and combination therapies

Wheeler MB, Lu M, Dillon JS, Leng XH, Chen C, and Boyd AE, 3rd

Although these results are highly promising, long-term data including primary CV prevention populations and utilizing other SGLT2-I will be needed to fully assess the CV outcomes with this class of medications

Curr Pain Headache Rep 28(6):453456

2026 Also of Interest The science behind the hype: How do they work?, How are they made?, How safe are they?, and could they really be a panacea for the obesity epidemic?

These medications treated Type 2 diabetes for nearly two decades before becoming household names